Table 1 Patient characteristics
Whole population n = 16 | Rheumatology n = 8 | General Practice n = 8 | p | |
|---|---|---|---|---|
Women: n (%) | 11 (68.7%) | 6 (75%) | 5 (62.5%) | NS |
Age (years): mean (DS) [min- max] | 57.3 (14.4) [23–83] | 62.1 (12.9) [48–83] | 52.6 (15.9) [23–70] | p = 0.362 |
Job status: n (%) | p = 0.412 | |||
- Retirement | 7 (43.7%) | 4 (50%) | 3 (37.5%) | |
- Active | 6 (37.5%) | 2 (25%) | 4 (50%) | |
- Disability | 2 (12.5%) | 2 (25%) | 0 | |
- Student | 1 (6.25%) | 0 | 1 (12.5) | |
Chronic diseases: n (%) | p = 0.007 | |||
- Rheumatoid arthritis | 10 (62.5%) | 8 (100%) | 2 (25%) | |
- Giant cell arteritis | 2 (12.5%) 1 | 0 | 2 (25%) | |
- Eosinophilia | (6.25%) | 0 | 1 (12.5%) | |
- Auto-immune hepatitis | 1 (6.25%) | 0 | 1 (12.5%) | |
- Undifferentiated rheumatism | 1 (6.25%) | 0 | 1 (12.5%) | |
- Giant urticaria | 1 (6.25%) | 0 | 1 (12.5%) | |
Steroid duration (years): mean (ET) [min-max] | 9.53 (10.21) [0.5–28] | 15.2 (10.78) [0.5–28] | 3.88 (5.85) [0.5–16] | p = 0.046 |
Steroid dose over the last 3 months (mg EP), mean (ET) [min-max] | 8.37 (4.08) [5–17.5] | 9.3 (3.76) [5–15] | 7.4 (4.43) [5–17.5] | p = 0.119 |